Education
About Us
Working with TipRanks
Follow Us
ReproCELL Inc. (JP:4978)
:4978
4978 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥97.00 - ¥277.00
Previous CloseN/A
Volume331.50K
Average Volume (3M)2.36M
Market Cap
¥15.92B
Enterprise Value¥9.17B
Total Cash (Recent Filing)¥4.43B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)156.1
Beta0.65
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.45
Shares Outstanding94,802,895
10 Day Avg. Volume1,898,810
30 Day Avg. Volume2,356,380
Financial Highlights & Ratios
PEG Ratio-2.80
Price to Book (P/B)1.45
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.25% Public Companies and
Individual Investors
4978 FAQ
What was ReproCELL Inc.’s price range in the past 12 months?
ReproCELL Inc. lowest stock price was ¥97.00 and its highest was ¥277.00 in the past 12 months.
What is ReproCELL Inc.’s market cap?
ReproCELL Inc.’s market cap is ¥15.92B.
When is ReproCELL Inc.’s upcoming earnings report date?
ReproCELL Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 66 days.
How were ReproCELL Inc.’s earnings last quarter?
ReproCELL Inc. released its earnings results on May 14, 2025. The company reported ¥1.45 earnings per share for the quarter, beating the consensus estimate of N/A by ¥1.45.
Is ReproCELL Inc. overvalued?
According to Wall Street analysts ReproCELL Inc.’s price is currently Overvalued.
Does ReproCELL Inc. pay dividends?
ReproCELL Inc. does not currently pay dividends.
What is ReproCELL Inc.’s EPS estimate?
ReproCELL Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ReproCELL Inc. have?
ReproCELL Inc. has 94,802,895 shares outstanding.
What happened to ReproCELL Inc.’s price movement after its last earnings report?
ReproCELL Inc. reported an EPS of ¥1.45 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.229%.
Which hedge fund is a major shareholder of ReproCELL Inc.?
Currently, no hedge funds are holding shares in JP:4978
Company Description
ReproCELL Inc.
ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Technical Analysis
StemRIM Inc.
―
CellSource Co., Ltd.
―
StemCell Institute
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―